Cerebral and hepatic inflammatory response after neonatal hypoxia-ischemia in newborn rats

Developmental Neuroscience

Volumn 35, Issue 2-3, 2013, Pages 197-211

  Bonestroo, H J C ^a   Nijboer, C H A ^a   Van Velthoven, C T J ^a   Kavelaars, A ^a   Hack, C E ^a   Van Bel, F ^a   Heijnen, C J ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Cerebral inflammatory response; Hepatic inflammatory response; Neonatal hypoxia ischemia; Rats

Indexed keywords

CHEMOKINE; CINC 1 PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ARGINASE 1; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INTERLEUKIN 4; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CAROTID ARTERY OBSTRUCTION; COMPARATIVE STUDY; CONFERENCE PAPER; DOWN REGULATION; ENCEPHALITIS; FEMALE; GRANULOCYTE; HEPATITIS; HYPOXIA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; ISCHEMIA; MACROPHAGE; MALE; MICROGLIA; NEUTROPHIL CHEMOTAXIS; NEWBORN; NONHUMAN; PHENOTYPE; POLARIZATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SHAM PROCEDURE; UPREGULATION; BRAIN DAMAGE; CONTROLLED STUDY; GENE EXPRESSION; HEMISPHERE; HYPOXIC ISCHEMIC ENCEPHALOPATHY; LIVER DISEASE; LIVER METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANIMALS, NEWBORN; ANOXIA; CYTOKINES; HEPATITIS; HYPOXIA-ISCHEMIA, BRAIN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84880203868     PISSN: 03785866     EISSN: 14219859     Source Type: Journal    
DOI: 10.1159/000346685     Document Type: Conference Paper

References (72)

1. de Haan M, Wyatt JS, Roth S, Vargha-Khadem F, Gadian D, Mishkin M: Brain and cognitive-behavioural development after asphyxia at term birth. Dev Sci 2006; 9: 350-358.
2. Gonzalez FF, Miller SP: Does perinatal asphyxia impair cognitive function without cerebral palsy? Arch Dis Child Fetal Neonatal Ed 2006; 91:F454-F459.
3. van Handel M, Swaab H, de Vries LS, Jongmans MJ: Long-term cognitive and behavioral consequences of neonatal encephalopathy following perinatal asphyxia: A review. Eur J Pediatr 2007; 166: 645-654.
4. Armstrong-Wells J, Bernard TJ, Boada R, Manco-Johnson M: Neurocognitive outcomes following neonatal encephalopathy. NeuroRehabilitation 2010; 26: 27-33.
5. Glass HC, Hong KJ, Rogers EE, Jeremy RJ, Bonifacio SL, Sullivan JE, Barkovich AJ, Ferriero DM: Risk factors for epilepsy in children with neonatal encephalopathy. Pediatr Res 2011; 70: 535-540.
6. Wyatt JS, Gluckman PD, Liu PY, Azzopardi D, Ballard R, Edwards AD, Ferriero DM, Polin RA, Robertson CM, Thoresen M, Whitelaw A, Gunn AJ, CoolCap Study Group: Determinants of outcomes after head cooling for neonatal encephalopathy. Pediatrics 2007; 119: 912-921.
7. Graham EM, Ruis KA, Hartman AL, Northington FJ, Fox HE: A systematic review of the role of intrapartum hypoxia-ischemia in the causation of neonatal encephalopathy. Am J Obstet Gynecol 2008; 199: 587-595.
8. Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF, Fanaroff AA, Poole WK, Wright LL, Higgins RD, Finer NN, Carlo WA, Duara S, Oh W, Cotten CM, Stevenson DK, Stoll BJ, Lemons JA, Guillet R, Jobe AH, National Institute of Child Health and Human Development Neonatal Research Network: Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 2005; 353: 1574-1584.
9. Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, Ferriero DM, Polin RA, Robertson CM, Thoresen M, Whitelaw A, Gunn AJ: Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: Multicentre randomised trial. Lancet 2005; 365: 663-670.
10. Azzopardi DV, Strohm B, Edwards AD, Dyet L, Halliday HL, Juszczak E, Kapellou O, Levene M, Marlow N, Porter E, Thoresen M, Whitelaw A, Brocklehurst P, TOBY Study Group: Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med 2009; 361: 1349-1358.
11. Cao J, Xu J, Li W, Liu J: Influence of selective brain cooling on the expression of ICAM-1 mRNA and infiltration of PMNLs and monocytes/macrophages in rats suffering from global brain ischemia/reperfusion injury. Biosci Trends 2008; 2: 241-244.
12. Gunn AJ, Wyatt JS, Whitelaw A, Barks J, Azzopardi D, Ballard R, Edwards AD, Ferriero DM, Gluckman PD, Polin RA, Robertson CM, Thoresen M, CoolCap Study Group: Therapeutic hypothermia changes the prognostic value of clinical evaluation of neonatal encephalopathy. J Pediatr 2008; 152: 55-58, 58.e1.
13. Gonzalez-Ibarra FP, Varon J, Lopez-Meza EG: Therapeutic hypothermia: Critical review of the molecular mechanisms of action. Front Neurol 2011; 2: 4.
14. Williams GD, Dardzinski BJ, Buckalew AR, Smith MB: Modest hypothermia preserves cerebral energy metabolism during hypoxiaischemia and correlates with brain damage: A 31P nuclear magnetic resonance study in unanesthetized neonatal rats. Pediatr Res 1997; 42: 700-708.
15. Zhao H, Shimohata T, Wang JQ, Sun G, Schaal DW, Sapolsky RM, Steinberg GK: Akt contributes to neuroprotection by hypothermia against cerebral ischemia in rats. J Neurosci 2005; 25: 9794-9806.
16. Baker AJ, Zornow MH, Grafe MR, Scheller MS, Skilling SR, Smullin DH, Larson AA: Gypothermia prevents ischemia-induced increases in hippocampal glycine concentrations in rabbits. Stroke 1991; 22: 666-673.
17. Lin S, Rhodes PG, Cai Z: Whole body hypothermia broadens the therapeutic window of intranasally administered IGF-1 in a neonatal rat model of cerebral hypoxia-ischemia. Brain Res 2011; 1385: 246-256.
18. Robertson NJ, Bhakoo K, Puri BK, Edwards AD, Cox IJ: Gypothermia and amiloride preserve energetics in a neonatal brain slice model. Pediatr Res 2005; 58: 288-296.
19. Palmer C, Roberts RL, Young PI: Timing of neutrophil depletion influences long-term neuroprotection in neonatal rat hypoxicischemic brain injury. Pediatr Res 2004; 55: 549-556.
20. Hagberg H, Gilland E, Bona E, Hanson LA, Hahin-Zoric M, Blennow M, Holst M, McRae A, Soder O: Enhanced expression of interleukin (IL)-1 and IL-6 messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats. Pediatr Res 1996; 40: 603-609.
21. Silverstein FS, Barks JD, Hagan P, Liu XH, Ivacko J, Szaflarski J: Cytokines and perinatal brain injury. Neurochem Int 1997; 30: 375-383.
22. Hudome S, Palmer C, Roberts RL, Mauger D, Housman C, Towfighi J: The role of neutrophils in the production of hypoxic-ischemic brain injury in the neonatal rat. Pediatr Res 1997; 41: 607-616.
23. Silveira RC, Procianoy RS: Interleukin-6 and tumor necrosis factor-alpha levels in plasma and cerebrospinal fluid of term newborn infants with hypoxic-ischemic encephalopathy. J Pediatr 2003; 143: 625-629.
24. Hedtjarn M, Mallard C, Hagberg H: Inflammatory gene profiling in the developing mouse brain after hypoxia-ischemia. J Cereb Blood Flow Metab 2004; 24: 1333-1351.
25. van den Tweel ER, Kavelaars A, Lombardi MS, Nijboer CH, Groenendaal F, van Bel F, Heijnen CJ: Bilateral molecular changes in a neonatal rat model of unilateral hypoxic-ischemic brain damage. Pediatr Res 2006; 59: 434-439.
26. Aly H, Khashaba MT, El-Ayouty M, El-Sayed O, Hasanein BM: IL-1beta, IL-6 and TNF-alpha and outcomes of neonatal hypoxic ischemic encephalopathy. Brain Dev 2006; 28: 178-182.
27. Bona E, Andersson AL, Blomgren K, Gilland E, Puka-Sundvall M, Gustafson K, Hagberg H: Chemokine and inflammatory cell response to hypoxia-ischemia in immature rats. Pediatr Res 1999; 45: 500-509.
28. Dammann O, O'Shea TM: Cytokines and perinatal brain damage. Clin Perinatol 2008; 35: 643-663, v.
29. Nijboer CH, Heijnen CJ, Groenendaal F, May MJ, van Bel F, Kavelaars A: Strong neuroprotection by inhibition of NF-kappaB after neonatal hypoxia-ischemia involves apoptotic mechanisms but is independent of cytokines. Stroke 2008; 39: 2129-2137.
30. Jones TB, McDaniel EE, Popovich PG: Inflammatory-mediated injury and repair in the traumatically injured spinal cord. Curr Pharm Des 2005; 11: 1223-1236.
31. Lucas SM, Rothwell NJ, Gibson RM: The role of inflammation in CNS injury and disease. Br J Pharmacol 2006; 147(suppl 1):S232-S240.
32. Nijboer CH, Heijnen CJ, Groenendaal F, van Bel F, Kavelaars A: Alternate pathways preserve tumor necrosis factor-alpha production after nuclear factor-kappaB inhibition in neonatal cerebral hypoxia-ischemia. Stroke 2009; 40: 3362-3368.
33. Greenhalgh AD, Galea J, Denes A, Tyrrell PJ, Rothwell NJ: Rapid brain penetration of interleukin-1 receptor antagonist in rat cerebral ischaemia: Pharmacokinetics, distribution, protection. Br J Pharmacol 2010; 160: 153-159.
34. Anthony DC, Couch Y, Losey P, Evans MC: The systemic response to brain injury and disease. Brain Behav Immun 2012; 26: 534-540.
35. Wilcockson DC, Campbell SJ, Anthony DC, Perry VH: The systemic and local acute phase response following acute brain injury. J Cereb Blood Flow Metab 2002; 22: 318-326.
36. Campbell SJ, Hughes PM, Iredale JP, Wilcockson DC, Waters S, Docagne F, Perry VH, Anthony DC: CINC-1 is an acute-phase protein induced by focal brain injury causing leukocyte mobilization and liver injury. FASEB J 2003; 17: 1168-1170.
37. Campbell SJ, Perry VH, Pitossi FJ, Butchart AG, Chertoff M, Waters S, Dempster R, Anthony DC: Central nervous system injury triggers hepatic CC and CXC chemokine expression that is associated with leukocyte mobilization and recruitment to both the central nervous system and the liver. Am J Pathol 2005; 166: 1487-1497.
38. Campbell SJ, Zahid I, Losey P, Law S, Jiang Y, Bilgen M, van Rooijen N, Morsali D, Davis AE, Anthony DC: Liver Kupffer cells control the magnitude of the inflammatory response in the injured brain and spinal cord. Neuropharmacology 2008; 55: 780-787.
39. Campbell SJ, Anthony DC, Oakley F, Carlsen H, Elsharkawy AM, Blomhoff R, Mann DA: Gepatic nuclear factor kappa B regulates neutrophil recruitment to the injured brain. J Neuropathol Exp Neurol 2008; 67: 223-230.
40. Chapman KZ, Dale VQ, Denes A, Bennett G, Rothwell NJ, Allan SM, McColl BW: A rapid and transient peripheral inflammatory response precedes brain inflammation after experimental stroke. J Cereb Blood Flow Metab 2009; 29: 1764-1768.
41. Campbell SJ, Deacon RM, Jiang Y, Ferrari C, Pitossi FJ, Anthony DC: Overexpression of IL-1beta by adenoviral-mediated gene transfer in the rat brain causes a prolonged hepatic chemokine response, axonal injury and the suppression of spontaneous behaviour. Neurobiol Dis 2007; 27: 151-163.
42. Nijboer CH, Kavelaars A, Vroon A, Groenendaal F, van Bel F, Heijnen CJ: Low endogenous G-protein-coupled receptor kinase 2 sensitizes the immature brain to hypoxia-ischemia-induced gray and white matter damage. J Neurosci 2008; 28: 3324-3332.
43. Ashdown H, Joita S, Luheshi GN, Boksa P: Acute brain cytokine responses after global birth hypoxia in the rat. J Neurosci Res 2008; 86: 3401-3409.
44. Hellwig-Burgel T, Stiehl DP, Wagner AE, Metzen E, Jelkmann W: Review: Gypoxia-inducible factor-1 (HIF-1): A novel transcription factor in immune reactions. J Interferon Cytokine Res 2005; 25: 297-310.
45. Copple BL, Bai S, Burgoon LD, Moon JO: Gypoxia-inducible factor-1alpha regulates the expression of genes in hypoxic hepatic stellate cells important for collagen deposition and angiogenesis. Liver Int 2011; 31: 230-244.
46. Wenger RH: Mammalian oxygen sensing, signalling and gene regulation. J Exp Biol 2000; 203: 1253-1263.
47. Stroka DM, Burkhardt T, Desbaillets I, Wenger RH, Neil DA, Bauer C, Gassmann M, Candinas D: GIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J 2001; 15: 2445-2453.
48. McCloskey CA, Kameneva MV, Uryash A, Gallo DJ, Billiar TR: Tissue hypoxia activates JNK in the liver during hemorrhagic shock. Shock 2004; 22: 380-386.
49. Prass K, Meisel C, Hoflich C, Braun J, Halle E, Wolf T, Ruscher K, Victorov IV, Priller J, Dirnagl U, Volk HD, Meisel A: Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 2003; 198: 725-736.
50. Pavlov VA, Wang H, Czura CJ, Friedman SG, Tracey KJ: The cholinergic anti-inflammatory pathway: A missing link in neuroimmunomodulation. Mol Med 2003; 9: 125-134.
51. Meisel C, Schwab JM, Prass K, Meisel A, Dirnagl U: Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci 2005; 6: 775-786.
52. Chamorro A, Urra X, Planas AM: Infection after acute ischemic stroke: A manifestation of brain-induced immunodepression. Stroke 2007; 38: 1097-1103.
53. Woiciechowsky C, Asadullah K, Nestler D, Eberhardt B, Platzer C, Schoning B, Glockner F, Lanksch WR, Volk HD, Docke WD: Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat Med 1998; 4: 808-813.
54. Webster JI, Tonelli L, Sternberg EM: Neuroendocrine regulation of immunity. Annu Rev Immunol 2002; 20: 125-163.
55. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, Tracey KJ: Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405: 458-462.
56. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES: The sympathetic nerve - An integrative interface between two supersystems: The brain and the immune system. Pharmacol Rev 2000; 52: 595-638.
57. Procianoy RS: Gyperammonemia and perinatal asphyxia. Pediatrics 1981; 67: 578-579.
58. Esque-Ruiz MT, Figueras-Aloy J, Salvia-Roiges MD, Carbonell-Estrany X: Blood ammonia and transaminases in full term infants suffering from perinatal asphyxia. Rev Neurol 2003; 36: 801-805.
59. Lee A, Lingwood BE, Bjorkman ST, Miller SM, Poronnik P, Barnett NL, Colditz P, Pow DV: Rapid loss of glutamine synthetase from astrocytes in response to hypoxia: Implications for excitotoxicity. J Chem Neuroanat 2010; 39: 211-220.
60. Barnum SR, Ames RS, Maycox PR, Hadingham SJ, Meakin J, Harrison D, Parsons AA: Expression of the complement C3a and C5a receptors after permanent focal ischemia: An alternative interpretation. Glia 2002; 38: 169-173.
61. Lee HT, Emala CW, Joo JD, Kim M: Isoflurane improves survival and protects against renal and hepatic injury in murine septic peritonitis. Shock 2007; 27: 373-379.
62. Lv X, Yang L, Tao K, Liu Y, Yang T, Chen G, Yu W, Lv H, Wu F: Isoflurane preconditioning at clinically relevant doses induce protective effects of heme oxygenase-1 on hepatic ischemia reperfusion in rats. BMC Gastroenterol 2011; 11: 31.
63. Devlin LA, Nguyen MD, Figueroa E, Gordon LE, Feldhoff PW, Lassiter HA: Effects of endotoxin administration and cerebral hypoxiaischemia on complement activity and local transcriptional regulation in neonatal rats. Neurosci Lett 2005; 390: 109-113.
64. Kavelaars A, van de Pol M, Zijlstra J, Heijnen CJ: Beta 2-adrenergic activation enhances interleukin-8 production by human monocytes. J Neuroimmunol 1997; 77: 211-216.
65. Maher JJ, Scott MK, Saito JM, Burton MC: Adenovirus-mediated expression of cytokine-induced neutrophil chemoattractant in rat liver induces a neutrophilic hepatitis. Hepatology 1997; 25: 624-630.
66. Wittwer AJ, Carr LS, Zagorski J, Dolecki GJ, Crippes BA, De Larco JE: Gigh-level expression of cytokine-induced neutrophil chemoattractant (CINC) by a metastatic rat cell line: Purification and production of blocking antibodies. J Cell Physiol 1993; 156: 421-427.
67. Martinez FO, Helming L, Gordon S: Alternative activation of macrophages: An immunologic functional perspective. Annu Rev Immunol 2009; 27: 451-483.
68. Martinez FO: Regulators of macrophage activation. Eur J Immunol 2011; 41: 1531-1534.
69. Martinez FO, Sica A, Mantovani A, Locati M: Macrophage activation and polarization. Front Biosci 2008; 13: 453-461.
70. Mosser DM, Edwards JP: Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8: 958-969.
71. Gordon S, Martinez FO: Alternative activation of macrophages: Mechanism and functions. Immunity 2010; 32: 593-604.
72. Murray PJ, Wynn TA: Obstacles and opportunities for understanding macrophage polarization. J Leukoc Biol 2011; 89: 557-563.